KLK3 and prostate cancer: The MUC1 production patterns were precisely determined in benign (RWPE-1) and prostate cancer cells (LNCaP and PC3), with no significant interference from ascorbic and uric acids, vascular endothelial growth factor, BSA, and prostate specific antigen [146].